Abstract
Neonatal hypoglycemia is the most common metabolic disorder in newborns and can lead to neurological damage if untreated. While intravenous dextrose is the standard treatment, it is invasive. Oral 40% dextrose gel (0.5 ml/kg) offers a non-invasive alternative. A systematic review of five randomized controlled trials (RCTs), involving 2,742 neonates (1,326 received dextrose gel; 1,416 received placebo), assessed its effectiveness in reducing NICU admissions in neonates with blood glucose < 2.6 mmol/L. Although the overall meta-analysis showed a non-significant reduction in NICU admissions (risk ratio 0.68; 95% CI: 0.33–1.38; p = 0.28), a sensitivity analysis excluding one outlier study improved consistency (I² = 19%) and revealed a statistically significant reduction (risk ratio 0.52; 95% CI: 0.31–0.90; p = 0.02). These findings suggest that oral dextrose gel may reduce NICU admissions in neonates with hypoglycemia, but further large-scale studies are required to confirm its clinical effectiveness.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to the full article PDF.
USD 39.95
Prices may be subject to local taxes which are calculated during checkout




Similar content being viewed by others
Data availability
Data are available upon reasonable request.
References
Hay WW Jr, Raju TN, Higgins RD, Kalhan SC, Devaskar SU. Knowledge Gaps and Research Needs for Understanding and Treating Neonatal Hypoglycemia: Workshop Report from Eunice Kennedy Shriver National Institute of Child Health and Human Development. J Pediatr. 2009;155:612–7.
Harris DL, Weston PJ, Harding JE. Incidence of Neonatal Hypoglycemia in Babies Identified as at Risk. J Pediatr. 2012;161:787–91.
Pillai SK, Fhausiya VK. A cross-sectional study on the frequency and risk factors for neonatal hypoglycemia in babies born in rural Kerala. J Fam Med Prim Care. 2022;11:6949–54.
O’Brien M, Gilchrist C, Sadler L, Hegarty JE, Alsweiler JM. Infants eligible for neonatal hypoglycemia screening: a systematic review. JAMA Pediatr. 2023;177:1187–96.
Schneider H, Reiber W, Sager R, Malek A. Asymmetrical transport of glucose across the in vitro perfused human placenta. Placenta. 2003;24:27–33.
Holme AM, Roland MC, Lorentzen B, Michelsen TM, Henriksen T. Placental glucose transfer: a human in vivo study. PLoS ONE. 2015;10:e0117084.
Boluyt N, van Kempen A, Offringa M. Neurodevelopment after neonatal hypoglycemia: a systematic review and design of an optimal future study. Pediatrics. 2006;117:2231–43.
Shah R, Harding J, Brown J, McKinlay C. Neonatal glycaemia and neurodevelopmental outcomes: a systematic review and meta-analysis. Neonatology. 2019;115:116–26.
McKinlay CJ, Alsweiler JM, Anstice NS, Burakevych N, Chakraborty A, Chase JG, et al. Association of Neonatal Glycemia With Neurodevelopmental Outcomes at 4.5 Years. JAMA Pediatr. 2017;171:972–83.
Vain NE, Chiarelli F. Neonatal Hypoglycaemia: A Never-Ending Story? Neonatology. 2021;118:522–29.
Cornblath M, Ichord R. Hypoglycemia in the neonate. Semin Perinatol. 2000;24:136–49.
Sinclair JC. Approaches to the definition of neonatal hypoglycemia. Acta Paediatr Jpn. 1997;39:S17–20.
Neczypor JL, Holley SL. Providing evidence-based care during the golden hour. Nurs Women’s Health. 2017;21:462–72.
Sharma D. Golden 60 min of newborn’s life: Part 1: Preterm neonate. J Matern Fetal Neonatal Med. 2017;30:2716–27.
Harding JE, Harris D, Hegarty JE, Alsweiler JM, McKinlay CJD. An emerging evidence base for the management of neonatal hypoglycaemia. Early Hum Dev. 2017;104:51–6.
Levene I, Wilkinson D. Identification and management of neonatal hypoglycaemia in the full-term infant (British Association of Perinatal Medicine—Framework for Practice). Arch Dis Child Educ Pract Ed 2019;104:29–32.
Adamkin DH, Committee on Fetus and Newborn. Postnatal glucose homeostasis in late-preterm and term infants. Pediatrics. 2011;127:575–9.
Rozance PJ, Wolfsdorf JI. Hypoglycemia in the newborn. Pediatr Clin North Am. 2019;66:333–42.
Weston PJ, Harris DL, Harding JE. Dextrose gel treatment does not impair subsequent feeding. Arch Dis Child Fetal Neonatal Ed. 2017;102:539–41.
Edwards T, Liu G, Battin M, Harris DL, Hegarty JE, Weston PJ, et al. Oral dextrose gel for the treatment of hypoglycaemia in newborn infants. Cochrane Database Syst Rev. 2022;3:CD011027.
Gupta K, Amboiram P, Balakrishnan U, Abiramalatha T, Devi U. Dextrose gel for neonates at risk with asymptomatic hypoglycemia: a randomized clinical trial. Pediatrics. 2022;149:e2021050733.
Harding JE, Hegarty JE, Crowther CA, Edlin RP, Gamble GD, Alsweiler JM. hPOD Study Group. Evaluation of oral dextrose gel for prevention of neonatal hypoglycemia (hPOD): A multicenter, double-blind randomized controlled trial. PLoS Med. 2021;18:e1003411.
Chandrasekharan P, Lakshminrusimha S. Single dose of prophylactic oral dextrose gel reduces neonatal hypoglycaemia. BMJ Evid Based Med. 2017;22:62.
Tufanaru C, Munn Z, Aromataris E, Campbell J, Hopp L. Systematic reviews of effectiveness. Joanna Briggs Inst reviewer’s Man. 2017;19:3 https://reviewersmanual.joannabriggs.org/ (accessed 20 May 2024).
Comprehensive Meta-Analysis Version 3.0Borenstein, M Hedges, L Higgins, J Rothstein, H Biostat, Englewood, NJ (2022).
Higgins JP, Thompson SG. Quantifying heterogeneity in a meta‐analysis. Stat Methods Med. 2002;21:1539–58.
GRADE handbook, https://gdt.gradepro.org/app/handbook/handbook.html (accessed 20 May 2024).
Coors SM, Cousin JJ, Hagan JL, Kaiser JR. Prophylactic dextrose gel does not prevent neonatal hypoglycemia: a quasi-experimental pilot study. J Pediatr. 2018;198:156–61.
Harris DL, Gamble GD, Weston PJ, Harding JE. What Happens to Blood Glucose Concentrations After Oral Treatment for Neonatal Hypoglycemia? J Pediatr. 2017;190:136–41.
Harris DL, Weston PJ, Signal M, Chase JG, Harding JE. Dextrose gel for neonatal hypoglycaemia (the Sugar Babies Study): A randomised, double-blind, placebo-controlled trial. Lancet. 2013;382:2077–83.
Hegarty JE, Harding JE, Gamble GD, Crowther CA, Edlin R, Alsweiler JM. Prophylactic oral dextrose gel for newborn babies at risk of neonatal hypoglycaemia: a randomised controlled dose-finding trial (the Pre-hPOD Study). PLoS Med. 2016;13:e1002155.
Walravens C, Gupta A, Cohen RS, Kim JL, Frymoyer A. Fewer glucose checks and decreased supplementation using dextrose gel for asymptomatic neonatal hypoglycemia. J Perinatol 2023;43:532–37.
Parappil H, Gaffari M, Ahmed J, Skaria S, Rijims M, Chandra P, et al. Oral Dextrose gel use in asymptomatic hypoglycemic newborns decreases NICU admissions and parenteral dextrose therapy: A retrospective study. J Neonatal Perinat Med. 2023;16:111–17.
Griffith R, Hegarty JE, Alsweiler JM, Gamble GD, May R, McKinlay CJ, et al. Two-year outcomes after dextrose gel prophylaxis for neonatal hypoglycaemia. Arch Dis Child Fetal Neonatal Ed. 2021;106:278–85.
Meneghin F, Manzalini M, Acunzo M, Daniele I, Bastrenta P, Castoldi F, et al. Management of asymptomatic hypoglycemia with 40% oral dextrose gel in near term at-risk infants to reduce intensive care need and promote breastfeeding. Ital J Pediatr. 2021;47:1–8.
Rawat M, Chandrasekharan P, Turkovich S, Barclay N, Perry K, Schroeder E, et al. Oral Dextrose Gel Reduces the Need for Intravenous Dextrose Therapy in Neonatal Hypoglycemia. Biomed Hub. 2017;1:1–9.
Desai P, Verma S, Bhargava S, Rice M, Tracy J, Bradshaw C. Implementation and outcomes of a standard dose dextrose gel protocol for management of transient neonatal hypoglycemia. J Perinatol 2022;42:1097–02.
Stanzo K, Desai S, Chiruvolu A. Effects of Dextrose Gel in Newborns at Risk for Neonatal Hypoglycemia in a Baby-Friendly Hospital. J Obstet Gynecol Neonatal Nurs 2020;49:55–64.
Gregory K, Turner D, Benjamin CN, Monthe-Dreze C, Johnson L, Hurwitz S, et al. Incorporating dextrose gel and feeding in the treatment of neonatal hypoglycaemia. Arch Dis Child Fetal Neonatal Ed. 2020;105:45–49.
Glasgow MJ, Harding JE, Edlin R, Alsweiler J, Chase JG, Harris D, et al. Cost analysis of treating neonatal hypoglycemia with dextrose gel. J Pediatr. 2018;198:151–55.e1.
Harris DL, Alsweiler JM, Ansell JM, Gamble GD, Thompson B, Wouldes TA, et al. Outcome at 2 years after dextrose gel treatment for neonatal hypoglycemia: follow-up of a randomized trial. J Pediatr. 2016;170:54–59.e2.
Brown LD, Rozance PJ. A sweet addition for the treatment of neonatal hypoglycemia. J Pediatr. 2016;170:10–12.
Funding
The authors did not receive any specific grants from public, commercial, or not-for-profit funding agencies for this research.
Author information
Authors and Affiliations
Contributions
GS and SS: Conceptualization of the study, supervision, initial screening of studies, quality assessment of included studies, statistical analysis, manuscript drafting, and critical review of the manuscript, P K: Validation of results, supervision of screening of studies, quality assessment of included studies, and drafting of the discussion section, critical review and final approval of the manuscript, L P: Data collection, literature review, initial screening of studies, quality assessment of included studies, and drafting of the methodology section, A M: Supervision of data extraction, and critical revision of the manuscript.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Sivakumar, G., Kuppusamy, P., P, L.P. et al. Effectiveness of oral dextrose gel for neonates at risk of hypoglycemia: A systematic review, meta-analysis, and GRADE assessment of randomized controlled trials. J Perinatol 45, 1335–1344 (2025). https://doi.org/10.1038/s41372-025-02387-x
Received:
Revised:
Accepted:
Published:
Version of record:
Issue date:
DOI: https://doi.org/10.1038/s41372-025-02387-x
This article is cited by
-
Methodological flaws in a meta-analysis compromise the integrity of the evidence
Journal of Perinatology (2025)


